The state of Georgia currently has 14 active clinical trials seeking participants for Multiple Sclerosis research studies. These trials are conducted in various cities, including Atlanta, Augusta, Decatur and Savannah.
A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis
Recruiting
This is a Phase 1 study of IMS001, given as a single dose to subjects with Multiple Sclerosis who experience inadequate response and/or intolerability to disease modifying treatments. IMS001 is a human embryonic cell derived (hESC) mesenchymal stem cell (MSC). MSCs have the potential to modulate disease course.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
09/26/2023
Locations: Shepherd Center, Atlanta, Georgia
Conditions: Multiple Sclerosis
A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS)
Recruiting
PoNS therapy is a rehabilitation program that uses the PoNS device in conjunction with individualized physical exercise. This is an outcome research open label observational interventional multi-center study investigating the relationship between subject's adherence to PoNS therapy and therapeutic outcomes.
Gender:
All
Ages:
Between 22 years and 65 years
Trial Updated:
03/02/2023
Locations: Shepherd Center, Atlanta, Georgia
Conditions: Gait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)